Search Results - Emily Chan
- Showing 1 - 20 results of 64
- Go to Next Page
-
1
Mechanisms of CDC-42 activation during contact-induced cell polarization by Emily Chan, Jeremy Nance
Published 2013Artigo -
2
-
3
-
4
-
5
-
6
-
7
-
8
Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem c... by Nuzhat Ahmed, Ruth M. Escalona, Dilys T.H. Leung, Emily Chan, George Kannourakis
Published 2018Revisão -
9
-
10
Real-World Study of Characteristics and Treatment Outcomes Among Patients with <i>KRAS</i> p.G12C-Mutated or Other <i>KRAS</i> Mutated Metastatic Colorectal Cancer by Marwan Fakih, Huakang Tu, Hil Hsu, Shivani Aggarwal, Emily Chan, Marko Rehn, Victoria Chia, Scott Kopetz
Published 2022Artigo -
11
-
12
-
13
A Phase II Trial of Neoadjuvant Chemoradiation and Local Excision for T2N0 Rectal Cancer: Preliminary Results of the ACOSOG Z6041 Trial by Julio García‐Aguilar, Qian Shi, Charles R. Thomas, Emily Chan, Peter A. Cataldo, Jorge Marcet, David Medich, Alessio Pigazzi, Samuel Oommen, Mitchell C. Posner
Published 2011Artigo -
14
-
15
Target Fortification of Breast Milk with Fat, Protein, and Carbohydrates for Preterm Infants by Niels Rochow, Gerhard Fusch, Arum Choi, Lorraine Chessell, LouAnn Elliott, Kimberley McDonald, Elizabeth Kuiper, Margaret Purcha, Steve Turner, Emily Chan, Meng Yang Xia, Christoph Fusch
Published 2013Artigo -
16
A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors by Igor Puzanov, Colin R. Lindsay, Laura W. Goff, Jeff Sosman, Jill Gilbert, Jordan Berlin, Srinivasu Poondru, Ronit Simantov, Rich Gedrich, Andrew Stephens, Emily Chan, T.R. Jeffry Evans
Published 2014Artigo -
17
A phase 1 study of anti-TGFβ receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors by Anthony W. Tolcher, Jordan Berlin, Jan Cosaert, John Kauh, Emily Chan, Sarina A. Piha‐Paul, Alex Amaya, Shande Tang, Kyla Driscoll, Richard Kimbung, Siva Rama Prasad Kambhampati, Ivelina Gueorguieva, David S. Hong
Published 2017Artigo -
18
Phase I trial of vorinostat added to chemoradiation with capecitabine in pancreatic cancer by Emily Chan, Lori R. Arlinghaus, Dana B. Cardin, Laura W. Goff, Jordan Berlin, Alexander A. Parikh, Richard G. Abramson, Thomas E. Yankeelov, Scott W. Hiebert, Nipun B. Merchant, Srividya Bhaskara, Anuradha Chakravarthy
Published 2016Artigo -
19
Noncovalent Wild-type–Sparing Inhibitors of EGFR T790M by Ho‐June Lee, Gabriele Schaefer, Timothy P. Heffron, Lily Shao, Xiaofen Ye, Steve Sideris, Shiva Malek, Emily Chan, Mark Merchant, Hank La, Savita Ubhayakar, Robert L. Yauch, Valentina Pirazzoli, Katerina Politi, Jeff Settleman
Published 2012Artigo -
20
Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer T... by Preet Paul Singh, Qian Shi, Nathan R. Foster, Axel Grothey, Suresh Nair, Emily Chan, Anthony F. Shields, Richard M. Goldberg, Sharlene Gill, Morton S. Kahlenberg, Frank A. Sinicrope, Daniel J. Sargent, Steven R. Alberts
Published 2016Artigo
Search Tools:
Related Subjects
Medicine
Cancer
Internal medicine
Oncology
Biology
Colorectal cancer
Cancer research
Gene
Biochemistry
Genetics
Cell biology
KRAS
Chemistry
Gastroenterology
Surgery
Chemotherapy
Immunotherapy
Confidence interval
Mutation
Pharmacology
Hazard ratio
Immunology
Oxaliplatin
Adverse effect
Clinical trial
Cetuximab
Clinical endpoint
Disease
Nausea
Prostate cancer